Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion.
Pan Y, Liu X, Zhang W, Wang W, Wang H, Luo L, Jia K, Shao C, Mao S, Qiu T, Ni J, Yu J, Wang L, Chen B, Xiong A, Gao G, Chen X, Wu F, Zhou C, Wu C, Ren S.
Pan Y, et al. Among authors: wang h, wang w, wang l.
Lung Cancer. 2023 Jul;181:107233. doi: 10.1016/j.lungcan.2023.107233. Epub 2023 May 10.
Lung Cancer. 2023.
PMID: 37201296